image stringlengths 20 66 | question stringclasses 16
values | answer stringlengths 3 10.7k |
|---|---|---|
PMC1949822_F4_13072.jpg | What is shown in this image? | Cell and biofilm morphology of Salmonella Typhimurium UMR1 (wt) and its mutants MAE52 (csgD++), MAE51 (csgD), MAE14 (csgBA), MAE222 (bcsA) and MAE619 (bapA) after growth for 24 hours. The first column shows light microscope (LM) images (with a frame width of approx. 0.6 mm) before drying, the second column light micros... |
PMC1949822_F4_13064.jpg | What is the principal component of this image? | Cell and biofilm morphology of Salmonella Typhimurium UMR1 (wt) and its mutants MAE52 (csgD++), MAE51 (csgD), MAE14 (csgBA), MAE222 (bcsA) and MAE619 (bapA) after growth for 24 hours. The first column shows light microscope (LM) images (with a frame width of approx. 0.6 mm) before drying, the second column light micros... |
PMC1949822_F6_13090.jpg | What stands out most in this visual? | Salmonella Typhimurium UMR1 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images (with a frame width of approx. 0.6 mm) before drying, the second row light microscope images at the same magnification after drying and the third and fourth rows show AFM images at two different scan siz... |
PMC1949822_F6_13095.jpg | What is the central feature of this picture? | Salmonella Typhimurium UMR1 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images (with a frame width of approx. 0.6 mm) before drying, the second row light microscope images at the same magnification after drying and the third and fourth rows show AFM images at two different scan siz... |
PMC1949822_F6_13089.jpg | What is being portrayed in this visual content? | Salmonella Typhimurium UMR1 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images (with a frame width of approx. 0.6 mm) before drying, the second row light microscope images at the same magnification after drying and the third and fourth rows show AFM images at two different scan siz... |
PMC1949822_F6_13094.jpg | What does this image primarily show? | Salmonella Typhimurium UMR1 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images (with a frame width of approx. 0.6 mm) before drying, the second row light microscope images at the same magnification after drying and the third and fourth rows show AFM images at two different scan siz... |
PMC1949822_F6_13092.jpg | What is the main focus of this visual representation? | Salmonella Typhimurium UMR1 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images (with a frame width of approx. 0.6 mm) before drying, the second row light microscope images at the same magnification after drying and the third and fourth rows show AFM images at two different scan siz... |
PMC1949822_F6_13091.jpg | What's the most prominent thing you notice in this picture? | Salmonella Typhimurium UMR1 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images (with a frame width of approx. 0.6 mm) before drying, the second row light microscope images at the same magnification after drying and the third and fourth rows show AFM images at two different scan siz... |
PMC1949822_F6_13099.jpg | What is shown in this image? | Salmonella Typhimurium UMR1 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images (with a frame width of approx. 0.6 mm) before drying, the second row light microscope images at the same magnification after drying and the third and fourth rows show AFM images at two different scan siz... |
PMC1949822_F6_13101.jpg | What does this image primarily show? | Salmonella Typhimurium UMR1 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images (with a frame width of approx. 0.6 mm) before drying, the second row light microscope images at the same magnification after drying and the third and fourth rows show AFM images at two different scan siz... |
PMC1949822_F6_13098.jpg | What does this image primarily show? | Salmonella Typhimurium UMR1 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images (with a frame width of approx. 0.6 mm) before drying, the second row light microscope images at the same magnification after drying and the third and fourth rows show AFM images at two different scan siz... |
PMC1949822_F6_13088.jpg | What is the core subject represented in this visual? | Salmonella Typhimurium UMR1 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images (with a frame width of approx. 0.6 mm) before drying, the second row light microscope images at the same magnification after drying and the third and fourth rows show AFM images at two different scan siz... |
PMC1949822_F6_13097.jpg | What is the core subject represented in this visual? | Salmonella Typhimurium UMR1 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images (with a frame width of approx. 0.6 mm) before drying, the second row light microscope images at the same magnification after drying and the third and fourth rows show AFM images at two different scan siz... |
PMC1949822_F6_13100.jpg | What stands out most in this visual? | Salmonella Typhimurium UMR1 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images (with a frame width of approx. 0.6 mm) before drying, the second row light microscope images at the same magnification after drying and the third and fourth rows show AFM images at two different scan siz... |
PMC1949822_F6_13093.jpg | What is the dominant medical problem in this image? | Salmonella Typhimurium UMR1 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images (with a frame width of approx. 0.6 mm) before drying, the second row light microscope images at the same magnification after drying and the third and fourth rows show AFM images at two different scan siz... |
PMC1949822_F6_13096.jpg | What stands out most in this visual? | Salmonella Typhimurium UMR1 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images (with a frame width of approx. 0.6 mm) before drying, the second row light microscope images at the same magnification after drying and the third and fourth rows show AFM images at two different scan siz... |
PMC1949822_F7_13116.jpg | What's the most prominent thing you notice in this picture? | Salmonella Typhimurium MAE52 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images before drying, the second row light microscope images after drying and the third and fourth rows show AFM images at two different scan sizes. The frame width of each image is approx. 0.6 mm. |
PMC1949822_F7_13117.jpg | What does this image primarily show? | Salmonella Typhimurium MAE52 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images before drying, the second row light microscope images after drying and the third and fourth rows show AFM images at two different scan sizes. The frame width of each image is approx. 0.6 mm. |
PMC1949822_F7_13112.jpg | Describe the main subject of this image. | Salmonella Typhimurium MAE52 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images before drying, the second row light microscope images after drying and the third and fourth rows show AFM images at two different scan sizes. The frame width of each image is approx. 0.6 mm. |
PMC1949822_F7_13115.jpg | What is the main focus of this visual representation? | Salmonella Typhimurium MAE52 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images before drying, the second row light microscope images after drying and the third and fourth rows show AFM images at two different scan sizes. The frame width of each image is approx. 0.6 mm. |
PMC1949822_F7_13109.jpg | What is the core subject represented in this visual? | Salmonella Typhimurium MAE52 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images before drying, the second row light microscope images after drying and the third and fourth rows show AFM images at two different scan sizes. The frame width of each image is approx. 0.6 mm. |
PMC1949822_F7_13104.jpg | What is the dominant medical problem in this image? | Salmonella Typhimurium MAE52 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images before drying, the second row light microscope images after drying and the third and fourth rows show AFM images at two different scan sizes. The frame width of each image is approx. 0.6 mm. |
PMC1949822_F7_13106.jpg | What is being portrayed in this visual content? | Salmonella Typhimurium MAE52 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images before drying, the second row light microscope images after drying and the third and fourth rows show AFM images at two different scan sizes. The frame width of each image is approx. 0.6 mm. |
PMC1949822_F7_13111.jpg | What key item or scene is captured in this photo? | Salmonella Typhimurium MAE52 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images before drying, the second row light microscope images after drying and the third and fourth rows show AFM images at two different scan sizes. The frame width of each image is approx. 0.6 mm. |
PMC1949822_F7_13110.jpg | Can you identify the primary element in this image? | Salmonella Typhimurium MAE52 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images before drying, the second row light microscope images after drying and the third and fourth rows show AFM images at two different scan sizes. The frame width of each image is approx. 0.6 mm. |
PMC1949822_F7_13105.jpg | What does this image primarily show? | Salmonella Typhimurium MAE52 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images before drying, the second row light microscope images after drying and the third and fourth rows show AFM images at two different scan sizes. The frame width of each image is approx. 0.6 mm. |
PMC1949822_F7_13107.jpg | What key item or scene is captured in this photo? | Salmonella Typhimurium MAE52 biofilm development after 4, 8, 16 and 24 h. The first row shows light microscope images before drying, the second row light microscope images after drying and the third and fourth rows show AFM images at two different scan sizes. The frame width of each image is approx. 0.6 mm. |
PMC1949822_F8_13103.jpg | What is the main focus of this visual representation? | High resolution AFM images of pili-like fimbrial structures and flagella in the curli mutant MAE14 after 4 h at two different scan sizes. |
PMC1949822_F8_13102.jpg | What stands out most in this visual? | High resolution AFM images of pili-like fimbrial structures and flagella in the curli mutant MAE14 after 4 h at two different scan sizes. |
PMC1949823_F4_13120.jpg | What is shown in this image? | TLC analysis of C12-3-oxo-AHL produced by parent strain P. putida WCS358 (lane 1), by lon mutant derivative P. putida IBE4 (lane 2) and lon mutant derivative carrying a plasmid expressing Lon P. putida IBE4 (pBBRlon) (lane 3). Lane 4 contains the standards C10-3-oxo-AHL and C12-3-oxo-AHL. The AHLs were visualized with ... |
PMC1949823_F4_13119.jpg | Describe the main subject of this image. | TLC analysis of C12-3-oxo-AHL produced by parent strain P. putida WCS358 (lane 1), by lon mutant derivative P. putida IBE4 (lane 2) and lon mutant derivative carrying a plasmid expressing Lon P. putida IBE4 (pBBRlon) (lane 3). Lane 4 contains the standards C10-3-oxo-AHL and C12-3-oxo-AHL. The AHLs were visualized with ... |
PMC1950079_pone-0000810-g004_13127.jpg | What is the central feature of this picture? | Lung tumors in C/L858R+T790M mice require expression of mutant EGFR for tumor maintenance.A. Serial axial lung field MR images from a mouse administered dox for 21 weeks (W) and then fed a normal diet for the indicated amounts of time. Arrows indicate lung opacities; H, heart. B. Tumor volumes were quantified in the im... |
PMC1950079_pone-0000810-g004_13128.jpg | What is the main focus of this visual representation? | Lung tumors in C/L858R+T790M mice require expression of mutant EGFR for tumor maintenance.A. Serial axial lung field MR images from a mouse administered dox for 21 weeks (W) and then fed a normal diet for the indicated amounts of time. Arrows indicate lung opacities; H, heart. B. Tumor volumes were quantified in the im... |
PMC1950079_pone-0000810-g004_13123.jpg | What key item or scene is captured in this photo? | Lung tumors in C/L858R+T790M mice require expression of mutant EGFR for tumor maintenance.A. Serial axial lung field MR images from a mouse administered dox for 21 weeks (W) and then fed a normal diet for the indicated amounts of time. Arrows indicate lung opacities; H, heart. B. Tumor volumes were quantified in the im... |
PMC1950079_pone-0000810-g004_13129.jpg | Can you identify the primary element in this image? | Lung tumors in C/L858R+T790M mice require expression of mutant EGFR for tumor maintenance.A. Serial axial lung field MR images from a mouse administered dox for 21 weeks (W) and then fed a normal diet for the indicated amounts of time. Arrows indicate lung opacities; H, heart. B. Tumor volumes were quantified in the im... |
PMC1950096_F3_13137.jpg | What is the focal point of this photograph? | Hemocyte Location in Axon Guidance Mutants. In blue, RNA in situ hybridization showing expression for CG25C, a hemocyte probe. The CNS scaffold (brown) is stained with the BP102 antibody, and indicates the CNS phenotype. The ladder-like WT CNS is visible in WT; the collapsed phenotype is observed in slit, robo12 and sl... |
PMC1950096_F3_13132.jpg | What is the dominant medical problem in this image? | Hemocyte Location in Axon Guidance Mutants. In blue, RNA in situ hybridization showing expression for CG25C, a hemocyte probe. The CNS scaffold (brown) is stained with the BP102 antibody, and indicates the CNS phenotype. The ladder-like WT CNS is visible in WT; the collapsed phenotype is observed in slit, robo12 and sl... |
PMC1950096_F3_13133.jpg | What object or scene is depicted here? | Hemocyte Location in Axon Guidance Mutants. In blue, RNA in situ hybridization showing expression for CG25C, a hemocyte probe. The CNS scaffold (brown) is stained with the BP102 antibody, and indicates the CNS phenotype. The ladder-like WT CNS is visible in WT; the collapsed phenotype is observed in slit, robo12 and sl... |
PMC1950096_F3_13131.jpg | What can you see in this picture? | Hemocyte Location in Axon Guidance Mutants. In blue, RNA in situ hybridization showing expression for CG25C, a hemocyte probe. The CNS scaffold (brown) is stained with the BP102 antibody, and indicates the CNS phenotype. The ladder-like WT CNS is visible in WT; the collapsed phenotype is observed in slit, robo12 and sl... |
PMC1950096_F3_13135.jpg | What is the central feature of this picture? | Hemocyte Location in Axon Guidance Mutants. In blue, RNA in situ hybridization showing expression for CG25C, a hemocyte probe. The CNS scaffold (brown) is stained with the BP102 antibody, and indicates the CNS phenotype. The ladder-like WT CNS is visible in WT; the collapsed phenotype is observed in slit, robo12 and sl... |
PMC1950096_F4_13152.jpg | What is the main focus of this visual representation? | RNA Expression in APoGE for Common Genes in Axon Guidance and Time Course Relevant Clusters. (4a), (4c), (4d), (4g), (4h), (4i), (4j), (4k), (4q), (4r), ventral view. (4b), (4f), (4l), (4m), (4n), (4o), (4p), (4s) and (4t), lateral view. (4a) CycA is a cell cyclin whose mutants have severe defects in the commissures an... |
PMC1950096_F4_13151.jpg | What can you see in this picture? | RNA Expression in APoGE for Common Genes in Axon Guidance and Time Course Relevant Clusters. (4a), (4c), (4d), (4g), (4h), (4i), (4j), (4k), (4q), (4r), ventral view. (4b), (4f), (4l), (4m), (4n), (4o), (4p), (4s) and (4t), lateral view. (4a) CycA is a cell cyclin whose mutants have severe defects in the commissures an... |
PMC1950096_F4_13138.jpg | What is the dominant medical problem in this image? | RNA Expression in APoGE for Common Genes in Axon Guidance and Time Course Relevant Clusters. (4a), (4c), (4d), (4g), (4h), (4i), (4j), (4k), (4q), (4r), ventral view. (4b), (4f), (4l), (4m), (4n), (4o), (4p), (4s) and (4t), lateral view. (4a) CycA is a cell cyclin whose mutants have severe defects in the commissures an... |
PMC1950096_F4_13149.jpg | Can you identify the primary element in this image? | RNA Expression in APoGE for Common Genes in Axon Guidance and Time Course Relevant Clusters. (4a), (4c), (4d), (4g), (4h), (4i), (4j), (4k), (4q), (4r), ventral view. (4b), (4f), (4l), (4m), (4n), (4o), (4p), (4s) and (4t), lateral view. (4a) CycA is a cell cyclin whose mutants have severe defects in the commissures an... |
PMC1950096_F4_13147.jpg | What key item or scene is captured in this photo? | RNA Expression in APoGE for Common Genes in Axon Guidance and Time Course Relevant Clusters. (4a), (4c), (4d), (4g), (4h), (4i), (4j), (4k), (4q), (4r), ventral view. (4b), (4f), (4l), (4m), (4n), (4o), (4p), (4s) and (4t), lateral view. (4a) CycA is a cell cyclin whose mutants have severe defects in the commissures an... |
PMC1950096_F4_13141.jpg | What can you see in this picture? | RNA Expression in APoGE for Common Genes in Axon Guidance and Time Course Relevant Clusters. (4a), (4c), (4d), (4g), (4h), (4i), (4j), (4k), (4q), (4r), ventral view. (4b), (4f), (4l), (4m), (4n), (4o), (4p), (4s) and (4t), lateral view. (4a) CycA is a cell cyclin whose mutants have severe defects in the commissures an... |
PMC1950096_F4_13144.jpg | Can you identify the primary element in this image? | RNA Expression in APoGE for Common Genes in Axon Guidance and Time Course Relevant Clusters. (4a), (4c), (4d), (4g), (4h), (4i), (4j), (4k), (4q), (4r), ventral view. (4b), (4f), (4l), (4m), (4n), (4o), (4p), (4s) and (4t), lateral view. (4a) CycA is a cell cyclin whose mutants have severe defects in the commissures an... |
PMC1950096_F4_13150.jpg | What's the most prominent thing you notice in this picture? | RNA Expression in APoGE for Common Genes in Axon Guidance and Time Course Relevant Clusters. (4a), (4c), (4d), (4g), (4h), (4i), (4j), (4k), (4q), (4r), ventral view. (4b), (4f), (4l), (4m), (4n), (4o), (4p), (4s) and (4t), lateral view. (4a) CycA is a cell cyclin whose mutants have severe defects in the commissures an... |
PMC1950096_F4_13143.jpg | What is the central feature of this picture? | RNA Expression in APoGE for Common Genes in Axon Guidance and Time Course Relevant Clusters. (4a), (4c), (4d), (4g), (4h), (4i), (4j), (4k), (4q), (4r), ventral view. (4b), (4f), (4l), (4m), (4n), (4o), (4p), (4s) and (4t), lateral view. (4a) CycA is a cell cyclin whose mutants have severe defects in the commissures an... |
PMC1950096_F4_13145.jpg | What is the core subject represented in this visual? | RNA Expression in APoGE for Common Genes in Axon Guidance and Time Course Relevant Clusters. (4a), (4c), (4d), (4g), (4h), (4i), (4j), (4k), (4q), (4r), ventral view. (4b), (4f), (4l), (4m), (4n), (4o), (4p), (4s) and (4t), lateral view. (4a) CycA is a cell cyclin whose mutants have severe defects in the commissures an... |
PMC1950096_F4_13148.jpg | What can you see in this picture? | RNA Expression in APoGE for Common Genes in Axon Guidance and Time Course Relevant Clusters. (4a), (4c), (4d), (4g), (4h), (4i), (4j), (4k), (4q), (4r), ventral view. (4b), (4f), (4l), (4m), (4n), (4o), (4p), (4s) and (4t), lateral view. (4a) CycA is a cell cyclin whose mutants have severe defects in the commissures an... |
PMC1950214_pmed-0040249-g001_13171.jpg | What is being portrayed in this visual content? | β-Catenin-Mediated TCF-Dependent Transcription Is Activated during Fracture Healing(A) Western blot analysis at different time points shows that β-catenin is elevated throughout healing in mice.(B) β-catenin is also increased during human fracture healing.(C–T) LacZ staining for TCF-dependent transcriptional activity i... |
PMC1950214_pmed-0040249-g001_13164.jpg | Describe the main subject of this image. | β-Catenin-Mediated TCF-Dependent Transcription Is Activated during Fracture Healing(A) Western blot analysis at different time points shows that β-catenin is elevated throughout healing in mice.(B) β-catenin is also increased during human fracture healing.(C–T) LacZ staining for TCF-dependent transcriptional activity i... |
PMC1950214_pmed-0040249-g001_13172.jpg | Can you identify the primary element in this image? | β-Catenin-Mediated TCF-Dependent Transcription Is Activated during Fracture Healing(A) Western blot analysis at different time points shows that β-catenin is elevated throughout healing in mice.(B) β-catenin is also increased during human fracture healing.(C–T) LacZ staining for TCF-dependent transcriptional activity i... |
PMC1950214_pmed-0040249-g001_13163.jpg | What key item or scene is captured in this photo? | β-Catenin-Mediated TCF-Dependent Transcription Is Activated during Fracture Healing(A) Western blot analysis at different time points shows that β-catenin is elevated throughout healing in mice.(B) β-catenin is also increased during human fracture healing.(C–T) LacZ staining for TCF-dependent transcriptional activity i... |
PMC1950214_pmed-0040249-g001_13166.jpg | What is the central feature of this picture? | β-Catenin-Mediated TCF-Dependent Transcription Is Activated during Fracture Healing(A) Western blot analysis at different time points shows that β-catenin is elevated throughout healing in mice.(B) β-catenin is also increased during human fracture healing.(C–T) LacZ staining for TCF-dependent transcriptional activity i... |
PMC1950214_pmed-0040249-g001_13174.jpg | What is shown in this image? | β-Catenin-Mediated TCF-Dependent Transcription Is Activated during Fracture Healing(A) Western blot analysis at different time points shows that β-catenin is elevated throughout healing in mice.(B) β-catenin is also increased during human fracture healing.(C–T) LacZ staining for TCF-dependent transcriptional activity i... |
PMC1950214_pmed-0040249-g001_13168.jpg | Describe the main subject of this image. | β-Catenin-Mediated TCF-Dependent Transcription Is Activated during Fracture Healing(A) Western blot analysis at different time points shows that β-catenin is elevated throughout healing in mice.(B) β-catenin is also increased during human fracture healing.(C–T) LacZ staining for TCF-dependent transcriptional activity i... |
PMC1950214_pmed-0040249-g001_13167.jpg | What does this image primarily show? | β-Catenin-Mediated TCF-Dependent Transcription Is Activated during Fracture Healing(A) Western blot analysis at different time points shows that β-catenin is elevated throughout healing in mice.(B) β-catenin is also increased during human fracture healing.(C–T) LacZ staining for TCF-dependent transcriptional activity i... |
PMC1950214_pmed-0040249-g001_13170.jpg | What is the dominant medical problem in this image? | β-Catenin-Mediated TCF-Dependent Transcription Is Activated during Fracture Healing(A) Western blot analysis at different time points shows that β-catenin is elevated throughout healing in mice.(B) β-catenin is also increased during human fracture healing.(C–T) LacZ staining for TCF-dependent transcriptional activity i... |
PMC1950214_pmed-0040249-g002_13184.jpg | Can you identify the primary element in this image? | β-Catenin Loss- or Gain-of-Function during the Initial Repair Phase Represses Fracture HealingAd-Cre and Ad-GFP (control) viruses were injected into fractures of Catnblox(ex3) or Catnbtm2Kem (Cre-null and Cre-Stab, respectively) transgenic mice.(A) Regulation of β-catenin protein by Cre recombinase-mediated recombinati... |
PMC1950214_pmed-0040249-g002_13177.jpg | What is the dominant medical problem in this image? | β-Catenin Loss- or Gain-of-Function during the Initial Repair Phase Represses Fracture HealingAd-Cre and Ad-GFP (control) viruses were injected into fractures of Catnblox(ex3) or Catnbtm2Kem (Cre-null and Cre-Stab, respectively) transgenic mice.(A) Regulation of β-catenin protein by Cre recombinase-mediated recombinati... |
PMC1950214_pmed-0040249-g002_13181.jpg | Can you identify the primary element in this image? | β-Catenin Loss- or Gain-of-Function during the Initial Repair Phase Represses Fracture HealingAd-Cre and Ad-GFP (control) viruses were injected into fractures of Catnblox(ex3) or Catnbtm2Kem (Cre-null and Cre-Stab, respectively) transgenic mice.(A) Regulation of β-catenin protein by Cre recombinase-mediated recombinati... |
PMC1950214_pmed-0040249-g002_13178.jpg | Can you identify the primary element in this image? | β-Catenin Loss- or Gain-of-Function during the Initial Repair Phase Represses Fracture HealingAd-Cre and Ad-GFP (control) viruses were injected into fractures of Catnblox(ex3) or Catnbtm2Kem (Cre-null and Cre-Stab, respectively) transgenic mice.(A) Regulation of β-catenin protein by Cre recombinase-mediated recombinati... |
PMC1950214_pmed-0040249-g002_13182.jpg | What is the main focus of this visual representation? | β-Catenin Loss- or Gain-of-Function during the Initial Repair Phase Represses Fracture HealingAd-Cre and Ad-GFP (control) viruses were injected into fractures of Catnblox(ex3) or Catnbtm2Kem (Cre-null and Cre-Stab, respectively) transgenic mice.(A) Regulation of β-catenin protein by Cre recombinase-mediated recombinati... |
PMC1950214_pmed-0040249-g002_13176.jpg | What can you see in this picture? | β-Catenin Loss- or Gain-of-Function during the Initial Repair Phase Represses Fracture HealingAd-Cre and Ad-GFP (control) viruses were injected into fractures of Catnblox(ex3) or Catnbtm2Kem (Cre-null and Cre-Stab, respectively) transgenic mice.(A) Regulation of β-catenin protein by Cre recombinase-mediated recombinati... |
PMC1950214_pmed-0040249-g002_13180.jpg | What is the core subject represented in this visual? | β-Catenin Loss- or Gain-of-Function during the Initial Repair Phase Represses Fracture HealingAd-Cre and Ad-GFP (control) viruses were injected into fractures of Catnblox(ex3) or Catnbtm2Kem (Cre-null and Cre-Stab, respectively) transgenic mice.(A) Regulation of β-catenin protein by Cre recombinase-mediated recombinati... |
PMC1950214_pmed-0040249-g002_13179.jpg | What can you see in this picture? | β-Catenin Loss- or Gain-of-Function during the Initial Repair Phase Represses Fracture HealingAd-Cre and Ad-GFP (control) viruses were injected into fractures of Catnblox(ex3) or Catnbtm2Kem (Cre-null and Cre-Stab, respectively) transgenic mice.(A) Regulation of β-catenin protein by Cre recombinase-mediated recombinati... |
PMC1950214_pmed-0040249-g005_13155.jpg | What key item or scene is captured in this photo? | Lithium Treatment Regulates Bone Mass at the Fracture SiteMice were treated with lithium starting either 2 wk before the fracture (early treatment) or 4 d after the fracture (late treatment).(A) β-catenin increased 3 wk after fracture in mice receiving either early or late lithium treatment.(B–D) Radiographic analysis ... |
PMC1950214_pmed-0040249-g005_13159.jpg | What stands out most in this visual? | Lithium Treatment Regulates Bone Mass at the Fracture SiteMice were treated with lithium starting either 2 wk before the fracture (early treatment) or 4 d after the fracture (late treatment).(A) β-catenin increased 3 wk after fracture in mice receiving either early or late lithium treatment.(B–D) Radiographic analysis ... |
PMC1950214_pmed-0040249-g005_13157.jpg | What object or scene is depicted here? | Lithium Treatment Regulates Bone Mass at the Fracture SiteMice were treated with lithium starting either 2 wk before the fracture (early treatment) or 4 d after the fracture (late treatment).(A) β-catenin increased 3 wk after fracture in mice receiving either early or late lithium treatment.(B–D) Radiographic analysis ... |
PMC1950214_pmed-0040249-g005_13154.jpg | What stands out most in this visual? | Lithium Treatment Regulates Bone Mass at the Fracture SiteMice were treated with lithium starting either 2 wk before the fracture (early treatment) or 4 d after the fracture (late treatment).(A) β-catenin increased 3 wk after fracture in mice receiving either early or late lithium treatment.(B–D) Radiographic analysis ... |
PMC1950307_F1_13185.jpg | What can you see in this picture? | A: Neoformation in the left lobe (CT imaging) B: Neofomation in the left lobe (MR imaging)) C: Angiography: no vision of the left hepatic lobe or neoformation. |
PMC1950307_F1_13186.jpg | What is the focal point of this photograph? | A: Neoformation in the left lobe (CT imaging) B: Neofomation in the left lobe (MR imaging)) C: Angiography: no vision of the left hepatic lobe or neoformation. |
PMC1950307_F1_13187.jpg | What is the focal point of this photograph? | A: Neoformation in the left lobe (CT imaging) B: Neofomation in the left lobe (MR imaging)) C: Angiography: no vision of the left hepatic lobe or neoformation. |
PMC1950478_F1_13189.jpg | What is the main focus of this visual representation? | Chest radiograph shows bilateral perihilar alveolar opacities. |
PMC1950485_F2_13190.jpg | What is the central feature of this picture? | Tracheal stricture after invasion of adjacent thyroid cancer. Axial CT shows parenchymal irregularity and enlargement of the right thyroid lobe. The mass has eroded the right lateral tracheal wall and extended intraluminal to the trachea. Reformatted virtual endoscopy images portray the eccentric tracheal stenosis with... |
PMC1950503_F5_13203.jpg | What object or scene is depicted here? | Effect of the fungal metabolite mixtures on caspase 3-like activity, chromatin condensation and ultrastructure of soybean cells. Panel a and b: caspase 3-like activity in cells treated for 30 min with >3 kDa (a, black boxes) and <3 kDa (b, grey boxes) fractions of the metabolite mixtures. Control cells (Co, white boxes... |
PMC1950503_F5_13205.jpg | What is the central feature of this picture? | Effect of the fungal metabolite mixtures on caspase 3-like activity, chromatin condensation and ultrastructure of soybean cells. Panel a and b: caspase 3-like activity in cells treated for 30 min with >3 kDa (a, black boxes) and <3 kDa (b, grey boxes) fractions of the metabolite mixtures. Control cells (Co, white boxes... |
PMC1950503_F5_13197.jpg | What's the most prominent thing you notice in this picture? | Effect of the fungal metabolite mixtures on caspase 3-like activity, chromatin condensation and ultrastructure of soybean cells. Panel a and b: caspase 3-like activity in cells treated for 30 min with >3 kDa (a, black boxes) and <3 kDa (b, grey boxes) fractions of the metabolite mixtures. Control cells (Co, white boxes... |
PMC1950503_F5_13202.jpg | What can you see in this picture? | Effect of the fungal metabolite mixtures on caspase 3-like activity, chromatin condensation and ultrastructure of soybean cells. Panel a and b: caspase 3-like activity in cells treated for 30 min with >3 kDa (a, black boxes) and <3 kDa (b, grey boxes) fractions of the metabolite mixtures. Control cells (Co, white boxes... |
PMC1950519_F4_13212.jpg | What is the core subject represented in this visual? | Effect of PXD Cisplatin on βIII-tubulin stained PC12 cells. Differentiated PC12 cells were incubated with Cisplatin alone or in combination with PXD for 24 hrs then fixed and immunostained for the neuronal marker βIII-tubulin. A) Control cultures showed a large percentage of cells with long neurites, which were also pr... |
PMC1950519_F4_13207.jpg | Can you identify the primary element in this image? | Effect of PXD Cisplatin on βIII-tubulin stained PC12 cells. Differentiated PC12 cells were incubated with Cisplatin alone or in combination with PXD for 24 hrs then fixed and immunostained for the neuronal marker βIII-tubulin. A) Control cultures showed a large percentage of cells with long neurites, which were also pr... |
PMC1950519_F4_13208.jpg | What key item or scene is captured in this photo? | Effect of PXD Cisplatin on βIII-tubulin stained PC12 cells. Differentiated PC12 cells were incubated with Cisplatin alone or in combination with PXD for 24 hrs then fixed and immunostained for the neuronal marker βIII-tubulin. A) Control cultures showed a large percentage of cells with long neurites, which were also pr... |
PMC1950519_F4_13210.jpg | What can you see in this picture? | Effect of PXD Cisplatin on βIII-tubulin stained PC12 cells. Differentiated PC12 cells were incubated with Cisplatin alone or in combination with PXD for 24 hrs then fixed and immunostained for the neuronal marker βIII-tubulin. A) Control cultures showed a large percentage of cells with long neurites, which were also pr... |
PMC1950568_pone-0000812-g003_13215.jpg | What is the main focus of this visual representation? | Representative pictures of the enlarged adipocytes from South Asian (left panel) and Caucasian (right panel) volunteers.Both images were obtained with SPOT digital camera using 10× magnification. |
PMC1950688_pone-0000839-g002_13220.jpg | What is the main focus of this visual representation? | Histological analysis, funduscopy, and immunohistochemistry examination of the Slc4a3
−/− mouse retina.Retina cross-sections (20 µm-thick) from Slc4a3
+/+ (a) and Slc4a3
−/− (b) mice stained with hematoxylin-eosin, scale bar = 50 µm. Electron micrographs of Slc4a3
+/+ (c) and Slc4a3
−/− (d) mouse retinas, scale bar = 5... |
PMC1950688_pone-0000839-g002_13221.jpg | Describe the main subject of this image. | Histological analysis, funduscopy, and immunohistochemistry examination of the Slc4a3
−/− mouse retina.Retina cross-sections (20 µm-thick) from Slc4a3
+/+ (a) and Slc4a3
−/− (b) mice stained with hematoxylin-eosin, scale bar = 50 µm. Electron micrographs of Slc4a3
+/+ (c) and Slc4a3
−/− (d) mouse retinas, scale bar = 5... |
PMC1950688_pone-0000839-g002_13217.jpg | What is being portrayed in this visual content? | Histological analysis, funduscopy, and immunohistochemistry examination of the Slc4a3
−/− mouse retina.Retina cross-sections (20 µm-thick) from Slc4a3
+/+ (a) and Slc4a3
−/− (b) mice stained with hematoxylin-eosin, scale bar = 50 µm. Electron micrographs of Slc4a3
+/+ (c) and Slc4a3
−/− (d) mouse retinas, scale bar = 5... |
PMC1950688_pone-0000839-g002_13222.jpg | What is the central feature of this picture? | Histological analysis, funduscopy, and immunohistochemistry examination of the Slc4a3
−/− mouse retina.Retina cross-sections (20 µm-thick) from Slc4a3
+/+ (a) and Slc4a3
−/− (b) mice stained with hematoxylin-eosin, scale bar = 50 µm. Electron micrographs of Slc4a3
+/+ (c) and Slc4a3
−/− (d) mouse retinas, scale bar = 5... |
PMC1950688_pone-0000839-g002_13226.jpg | What is the core subject represented in this visual? | Histological analysis, funduscopy, and immunohistochemistry examination of the Slc4a3
−/− mouse retina.Retina cross-sections (20 µm-thick) from Slc4a3
+/+ (a) and Slc4a3
−/− (b) mice stained with hematoxylin-eosin, scale bar = 50 µm. Electron micrographs of Slc4a3
+/+ (c) and Slc4a3
−/− (d) mouse retinas, scale bar = 5... |
PMC1950688_pone-0000839-g002_13219.jpg | Can you identify the primary element in this image? | Histological analysis, funduscopy, and immunohistochemistry examination of the Slc4a3
−/− mouse retina.Retina cross-sections (20 µm-thick) from Slc4a3
+/+ (a) and Slc4a3
−/− (b) mice stained with hematoxylin-eosin, scale bar = 50 µm. Electron micrographs of Slc4a3
+/+ (c) and Slc4a3
−/− (d) mouse retinas, scale bar = 5... |
PMC1950688_pone-0000839-g002_13223.jpg | What is the principal component of this image? | Histological analysis, funduscopy, and immunohistochemistry examination of the Slc4a3
−/− mouse retina.Retina cross-sections (20 µm-thick) from Slc4a3
+/+ (a) and Slc4a3
−/− (b) mice stained with hematoxylin-eosin, scale bar = 50 µm. Electron micrographs of Slc4a3
+/+ (c) and Slc4a3
−/− (d) mouse retinas, scale bar = 5... |
PMC1950688_pone-0000839-g002_13216.jpg | What is shown in this image? | Histological analysis, funduscopy, and immunohistochemistry examination of the Slc4a3
−/− mouse retina.Retina cross-sections (20 µm-thick) from Slc4a3
+/+ (a) and Slc4a3
−/− (b) mice stained with hematoxylin-eosin, scale bar = 50 µm. Electron micrographs of Slc4a3
+/+ (c) and Slc4a3
−/− (d) mouse retinas, scale bar = 5... |
PMC1950688_pone-0000839-g002_13224.jpg | What is the focal point of this photograph? | Histological analysis, funduscopy, and immunohistochemistry examination of the Slc4a3
−/− mouse retina.Retina cross-sections (20 µm-thick) from Slc4a3
+/+ (a) and Slc4a3
−/− (b) mice stained with hematoxylin-eosin, scale bar = 50 µm. Electron micrographs of Slc4a3
+/+ (c) and Slc4a3
−/− (d) mouse retinas, scale bar = 5... |
PMC1950688_pone-0000839-g002_13218.jpg | What is the main focus of this visual representation? | Histological analysis, funduscopy, and immunohistochemistry examination of the Slc4a3
−/− mouse retina.Retina cross-sections (20 µm-thick) from Slc4a3
+/+ (a) and Slc4a3
−/− (b) mice stained with hematoxylin-eosin, scale bar = 50 µm. Electron micrographs of Slc4a3
+/+ (c) and Slc4a3
−/− (d) mouse retinas, scale bar = 5... |
PMC1950713_F5_13227.jpg | What is the focal point of this photograph? | Effect of HIF2α on tumour necrosis and late proliferation. a) Macroscopic observations of tumour nodules and b) histological analyses of Masson's trichrome stained sections reveal extended necrotic areas within day 28-HIF2α(1–485) expressing neuroblastomas, compared to control tumours. Such defects are less often obser... |
PMC1950713_F5_13237.jpg | What is the focal point of this photograph? | Effect of HIF2α on tumour necrosis and late proliferation. a) Macroscopic observations of tumour nodules and b) histological analyses of Masson's trichrome stained sections reveal extended necrotic areas within day 28-HIF2α(1–485) expressing neuroblastomas, compared to control tumours. Such defects are less often obser... |
PMC1950713_F5_13229.jpg | What is the principal component of this image? | Effect of HIF2α on tumour necrosis and late proliferation. a) Macroscopic observations of tumour nodules and b) histological analyses of Masson's trichrome stained sections reveal extended necrotic areas within day 28-HIF2α(1–485) expressing neuroblastomas, compared to control tumours. Such defects are less often obser... |
PMC1950713_F5_13235.jpg | What is the central feature of this picture? | Effect of HIF2α on tumour necrosis and late proliferation. a) Macroscopic observations of tumour nodules and b) histological analyses of Masson's trichrome stained sections reveal extended necrotic areas within day 28-HIF2α(1–485) expressing neuroblastomas, compared to control tumours. Such defects are less often obser... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.